Denali Therapeutics
DNLI
DNLI
118 hedge funds and large institutions have $1.09B invested in Denali Therapeutics in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.38% less ownership
Funds ownership: 74.94% → 74.56% (-0.38%)
26% less capital invested
Capital invested by funds: $1.49B → $1.09B (-$391M)
50% less call options, than puts
Call options by funds: $871K | Put options by funds: $1.75M
Holders
118
Holding in Top 10
3
Calls
$871K
Puts
$1.75M
Top Buyers
| 1 | +$4.38M | |
| 2 | +$3.83M | |
| 3 | +$2.97M | |
| 4 |
Bank of New York Mellon
New York
|
+$1.71M |
| 5 |
Millennium Management
New York
|
+$1.56M |
Top Sellers
| 1 | -$8.83M | |
| 2 | -$6.04M | |
| 3 | -$2.5M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.15M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.12M |